Grampet entered the shareholders structure of Polisano factory a few months ago through a RON13.4 million capital infusion, according to Official Gazette data.
“We have decided to invest in Polisano as it is an important name on the market and the oncologic drugs factory has got potential. It is, somehow, an ideal situation: a startup with high potential and a well-known name,” said Gruia Stoica.
Medical drugs factory Polisano Pharmaceuticals, an investment of EUR70 million of the Polisano group, was established in 2015. The factory located in the city of Sibiu is the largest oncologic drugs production facility in Central and Eastern Europe (CEE).
Polisano Pharmaceuticals covers 33,000 square meters and has over 400 equipment and manufacturing lines, with a production capacity of 32 million commercial units, the equivalent of 682 million pharmaceutical units.